title: Short-term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects.
abstract: To test whether de novo synthesis of cholesterol is a limiting factor for bile acid synthesis, we studied the acute effect of simvastatin, an inhibitor of HMG-coenzyme A reductase (the limiting step of cholesterol synthesis) on bile acid synthesis and biliary lipid secretion in subjects with interrupted enterohepatic circulation. In these conditions bile acid synthesis is derepressed and is assumed to equal biliary bile acid secretion. Five cholecystectomized patients fitted with T-tubes were studied. All subjects were administered simvastatin (80 mg as a single dose) 5 days after surgery. Bile was collected in 3-hr intervals for 15 hr before and 30 hr after the administration of the drug. During the experiment we kept the enterohepatic circulation of bile acid interrupted by inflating an occludable balloon inserted, during cholecystectomy, in the common bile duct. Simvastatin induced significant decreases of plasma total and low density lipoprotein cholesterol concentrations, from 163 +/- 29 mg/dl and 97 +/- 24 mg/dl of the pretreatment value to 144 +/- 30 mg/dl and 82 +/- 22 mg/dl 18 hr after simvastatin administration, respectively. Bile flow tended to increase after simvastatin, and the mean values from the third to the 15th hour after simvastatin administration (22.1 +/- 1.9 ml/hr) were significantly greater than the mean values of the pretreatment period (19.9 +/- 2.8 ml/hr). Concomitantly biliary bile acid, cholesterol and phospholipid concentrations fell from basal values of 15.9 +/- 5.1, 2.3 +/- 0.3 and 5.5 +/- 0.3 mmol/L to mean values, after treatment, of 9.0 +/- 3.5, 1.9 +/- 0.5 and 3.0 +/- 0.9 mmol/L, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Istituto di Patologia Speciale Medica, Università di Modena, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Loria
authors.forename: M
authors.initials: M
authors.lastname: Bertolotti
authors.forename: M T
authors.initials: MT
authors.lastname: Cassinadri
authors.forename: M A
authors.initials: MA
authors.lastname: Dilengite
authors.forename: M
authors.initials: M
authors.lastname: Bozzoli
authors.forename: F
authors.initials: F
authors.lastname: Carubbi
authors.forename: M
authors.initials: M
authors.lastname: Concari
authors.forename: M E
authors.initials: ME
authors.lastname: Guicciardi
authors.forename: N
authors.initials: N
authors.lastname: Carulli
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D001646:Bile / Q000737:chemistry / Q000502:physiology; D001647:Bile Acids and Salts / Q000096:biosynthesis*; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000378:metabolism; D019821:Simvastatin
chemical_list: D001647:Bile Acids and Salts; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010743:Phospholipids; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin